IMMUNOME INC (IMNM) Fundamental Analysis & Valuation

NASDAQ:IMNM • US45257U1088

Current stock price

19.61 USD
-0.8 (-3.92%)
At close:
19.61 USD
0 (0%)
After Hours:

This IMNM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IMNM Profitability Analysis

1.1 Basic Checks

  • In the past year IMNM has reported negative net income.
  • In the past year IMNM has reported a negative cash flow from operations.
  • In the past 5 years IMNM always reported negative net income.
  • IMNM had a negative operating cash flow in each of the past 5 years.
IMNM Yearly Net Income VS EBIT VS OCF VS FCFIMNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

  • The Return On Assets of IMNM (-31.09%) is better than 64.93% of its industry peers.
  • IMNM's Return On Equity of -33.48% is fine compared to the rest of the industry. IMNM outperforms 72.83% of its industry peers.
Industry RankSector Rank
ROA -31.09%
ROE -33.48%
ROIC N/A
ROA(3y)-74.98%
ROA(5y)-84.72%
ROE(3y)-94.76%
ROE(5y)-112.18%
ROIC(3y)N/A
ROIC(5y)N/A
IMNM Yearly ROA, ROE, ROICIMNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IMNM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMNM Yearly Profit, Operating, Gross MarginsIMNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. IMNM Health Analysis

2.1 Basic Checks

  • IMNM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IMNM has more shares outstanding
  • IMNM has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMNM Yearly Shares OutstandingIMNM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IMNM Yearly Total Debt VS Total AssetsIMNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • IMNM has an Altman-Z score of 25.82. This indicates that IMNM is financially healthy and has little risk of bankruptcy at the moment.
  • IMNM's Altman-Z score of 25.82 is amongst the best of the industry. IMNM outperforms 91.71% of its industry peers.
  • There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.82
ROIC/WACCN/A
WACC9.37%
IMNM Yearly LT Debt VS Equity VS FCFIMNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • IMNM has a Current Ratio of 14.69. This indicates that IMNM is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of IMNM (14.69) is better than 91.91% of its industry peers.
  • A Quick Ratio of 14.69 indicates that IMNM has no problem at all paying its short term obligations.
  • The Quick ratio of IMNM (14.69) is better than 91.91% of its industry peers.
Industry RankSector Rank
Current Ratio 14.69
Quick Ratio 14.69
IMNM Yearly Current Assets VS Current LiabilitesIMNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IMNM Growth Analysis

3.1 Past

  • IMNM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.00%, which is quite impressive.
  • The Revenue for IMNM has decreased by -23.23% in the past year. This is quite bad
EPS 1Y (TTM)53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)-23.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.79% on average over the next years. This is a very strong growth
  • IMNM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 141.10% yearly.
EPS Next Y-10.54%
EPS Next 2Y2.59%
EPS Next 3Y15.58%
EPS Next 5Y23.79%
Revenue Next Year-10.96%
Revenue Next 2Y230.58%
Revenue Next 3Y216.45%
Revenue Next 5Y141.1%

3.3 Evolution

IMNM Yearly Revenue VS EstimatesIMNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
IMNM Yearly EPS VS EstimatesIMNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. IMNM Valuation Analysis

4.1 Price/Earnings Ratio

  • IMNM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IMNM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMNM Price Earnings VS Forward Price EarningsIMNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMNM Per share dataIMNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IMNM's earnings are expected to grow with 15.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y15.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMNM Dividend Analysis

5.1 Amount

  • No dividends for IMNM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMNM Fundamentals: All Metrics, Ratios and Statistics

IMMUNOME INC

NASDAQ:IMNM (3/27/2026, 8:26:01 PM)

After market: 19.61 0 (0%)

19.61

-0.8 (-3.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners105.33%
Inst Owner Change14.04%
Ins Owners1.22%
Ins Owner Change-5.6%
Market Cap2.22B
Revenue(TTM)6.94M
Net Income(TTM)-212.39M
Analysts85
Price Target35.96 (83.38%)
Short Float %17.58%
Short Ratio11.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.37%
Min EPS beat(2)-23.77%
Max EPS beat(2)-10.97%
EPS beat(4)2
Avg EPS beat(4)-0.57%
Min EPS beat(4)-23.77%
Max EPS beat(4)25.15%
EPS beat(8)2
Avg EPS beat(8)-57.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)2
Avg Revenue beat(4)288.78%
Min Revenue beat(4)-100%
Max Revenue beat(4)904.04%
Revenue beat(8)3
Avg Revenue beat(8)137.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.95%
PT rev (3m)2.92%
EPS NQ rev (1m)7.36%
EPS NQ rev (3m)6.11%
EPS NY rev (1m)-0.43%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)-12.5%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20.5%
Revenue NY rev (3m)-20.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 319.62
P/FCF N/A
P/OCF N/A
P/B 3.5
P/tB 3.5
EV/EBITDA N/A
EPS(TTM)-2.43
EYN/A
EPS(NY)-2.69
Fwd EYN/A
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.69
OCFYN/A
SpS0.06
BVpS5.61
TBVpS5.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.09%
ROE -33.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.98%
ROA(5y)-84.72%
ROE(3y)-94.76%
ROE(5y)-112.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 646.03%
Cap/Sales 229.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.69
Quick Ratio 14.69
Altman-Z 25.82
F-Score5
WACC9.37%
ROIC/WACCN/A
Cap/Depr(3y)1414.18%
Cap/Depr(5y)862.52%
Cap/Sales(3y)275.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y-10.54%
EPS Next 2Y2.59%
EPS Next 3Y15.58%
EPS Next 5Y23.79%
Revenue 1Y (TTM)-23.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-10.96%
Revenue Next 2Y230.58%
Revenue Next 3Y216.45%
Revenue Next 5Y141.1%
EBIT growth 1Y-39.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.32%
OCF growth 3YN/A
OCF growth 5YN/A

IMMUNOME INC / IMNM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMMUNOME INC (IMNM) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMNM.


What is the valuation status of IMMUNOME INC (IMNM) stock?

ChartMill assigns a valuation rating of 0 / 10 to IMMUNOME INC (IMNM). This can be considered as Overvalued.


What is the profitability of IMNM stock?

IMMUNOME INC (IMNM) has a profitability rating of 1 / 10.


What is the financial health of IMMUNOME INC (IMNM) stock?

The financial health rating of IMMUNOME INC (IMNM) is 8 / 10.